A miscellany of news and happenings
Several of IBEC’s investigators are taking part in major events and meetings or appearing in the media in the next few days.
Several of IBEC’s investigators are taking part in major events and meetings or appearing in the media in the next few days.
This morning, IBEC’s now ex-director Josep A. Planell was formally inaugurated as rector of the Universitat Oberta de Catalunya (UoC) at a ceremony at the organisation’s headquarters in Barcelona.
A new director is being sought by the Institute for Bioengineering of Catalonia (IBEC).
In its capacity as coordinator of the Spanish Nanomedicine Platform (NanoMed Spain), IBEC was a key player at last week’s 6th Annual Conference of the Biomedical Research Technology Platforms in Madrid, which was organised by the four Spanish platforms working in the healthcare sectors.
IBEC Senior Researcher Joan Aranda’s project ‘InHANDS: robòtica interactiva per a l’assistència humana en l’entorn domèstic’ has been awarded funding by the RecerCaixa programme.
A new European Marie Curie Initial Training Network involving IBEC’s Nanoscale Bioelectrical Characterization group will attempt to bring research into microwaves – which are extensively used in a host of applications such as telecommunications, microwave ovens and radar – to a whole new level.
A new technology to combat dozing off when driving developed by IBEC, UB and industry partner Ficosa will be presented at this week’s GSMA World Mobile Congress in Barcelona.
About 130 researchers from IBEC and the Institut de Biologia Molecular de Barcelona (IBMB), which is also located in the Barcelona Science Park (PCB), got together yesterday for a joint workshop to identify synergies and possible areas for collaboration.
IBEC director Josep A. Planell took part in the public launch last night of a book to which he has contributed, “Ciència i universitat a Catalunya: Projecció de futur”.
Junior group leader Eduard Torrents is the recipient of a third “Pablo Motos” award from the Federación Española de Fibrosis Quística (FEFQ) to continue his research into identifying new antimicrobial molecules to fight the bacteria that cause complications and even death in many people with cystic fibrosis.